NGDC - GSA for Human

HRA001245

HRA001245.xlsx

Title:

Preclinical studies of stem cell therapy for neurological diseases using primate models

Release date:

2023-08-17

Description:

Depend on PD, ALS and RTT disease monkey models, different types of stem cells including ESCs, iPSCs and Neural stem cells or terminal differentiation cells were used for cell therapy research. Researches were carried out on compare the cells derived from human and monkey, as well as autologous and allogeneic cell transplantation. In order to solve the key scientific problems such as cell survival, differentiation, migration and functional reconstruction in vivo, avoid safety problems such as tumorigenesis or functional disorder caused by transplanted cells, realize regeneration, repair and functional reconstruction, and obtain safety and effectiveness data. To explore the effect of different transplantation methods or transplantation sites on the morphology and function of organs and its mechanism.

Data Accessibility:

Controlled access Request Data

BioProject:

PRJCA006201

Study type:

Disease Study

Disease name:

Parkinson's disease

Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.

DAC NO.:

HDAC000713

DAC name:

GSA_Sequence_20210818

Contact person:

Chen Zhiguo

Email:

chenzhiguo@gmail.com

Description:

GSA_Sequence_20210818

Aspera Command Line